Clinical Trial: Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients

U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274345) titled 'Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients' on Nov. 27.

Brief Summary: This study aims to determine the prevalence of antiviral drug resistance among Egyptian patients with chronic hepatitis B virus (HBV) infection and to identify the associated demographic, clinical, and virological risk factors. Understanding patterns of resistance will help improve treatment selection and optimize long-term management strategies for HBV patients.

Study Start Date: Dec. 01

Study Type: OBSERVATIONAL

Condition: Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection

Recruitment Statu...